CRYSTALLINE FORM OF GATIFLOXACIN

摘要

The present invention relates to a crystalline form of gatifoxacin (formula I) obtainable by process that comprises recrystallisation of the crude gatifloxacin in methanol and which is stable with a water content ranging between 2.5 and 4.5% by weight, to a process for preparing it and to the use thereof as an active substance in the preparation of pharmaceutical formulations.